Gimv

Complement Therapeutics operates as a preclinical stage company. Complement Therapeutics develops a precision medicine diagnostic platform allowing it to stratify patients based on their complement-activation profile with the potential to enable both patient selection and serving as an efficacy biomarker in future clinical studies.

ImCheck Therapeutics SAS is a biotechnology company incorporated in 2015 and based in Marseille, France. The company specializes in designing and developing immunotherapeutics that target the butyrophilin super-family of checkpoint molecules, specifically engaging γ9δ2 T cells. With a primary focus on immuno-oncology, ImCheck Therapeutics develops immunomodulatory antibodies aimed at treating various cancers, including breast, gastric, and ovarian cancers, as well as other immune-related diseases. The company is dedicated to addressing severe unmet medical needs through its innovative approach to cancer treatment and the development of next-generation immunotherapeutics.

ImmunOs Therapeutics AG is a clinical-stage biotechnology company based in Schlieren, Switzerland, founded in 2014. The company specializes in the discovery and development of novel human immunomodulatory proteins aimed at enhancing cancer treatment and addressing autoimmune diseases. By focusing on next-generation therapeutics, ImmunOs aims to create drugs that not only exhibit direct anti-tumor effects but also remodel the tumor microenvironment. Additionally, the company is developing antibodies designed to block the activation of specific HLA molecules associated with autoimmune conditions. Through its innovative approach, ImmunOs Therapeutics seeks to improve the lives of patients suffering from serious diseases.

BioConnection B.V. is a biopharmaceutical development and manufacturing service provider based in Oss, the Netherlands. Founded in 2005, the company specializes in supporting small and medium-sized biopharmaceutical firms by offering access to Good Manufacturing Practices (GMP) compliant facilities and expertise necessary for clinical trials and production. BioConnection provides a range of services, including clinical fill and finish, formulation development, manufacturing of active biopharmaceutical ingredients, process development, and stability studies. The company is recognized for its ability to produce small-scale clinical batches and facilitate large-scale commercial production, supported by a network of experienced suppliers. This capability is particularly valuable for emerging biopharmaceutical companies that may lack the resources or expertise for comprehensive clinical development. By acting as an independent intermediary, BioConnection simplifies the manufacturing process for its clients, ensuring timely and reliable product delivery.

Camel-IDS develops radiopharmaceuticals for cancer patients. Its product, CAM-H2, treats HER2 positive cancers. It also engages in clinical development to treat breast cancer patients; and develops compounds for other cancer indications. The company was incorporated in 2014 and is based in Brussels, Belgium.

Anjarium Biosciences is a transforming exosomes from cellular message couriers to potent therapeutic carriers for debilitating diseases. By harnessing the delivery propensity of our body’s natural communication network, we are forward engineering evolution to build a product engine for a new generation of targeted nanomedicines. Anjarium’s Hybridosome® platform creates unmatched advantages in the realm of engineering exosomes to address the therapeutic areas of cancer and rare genetic diseases.

Topas Therapeutics GmbH is a biotechnology company based in Hamburg, Germany, that specializes in developing nanoparticle-based therapeutics aimed at treating autoimmune diseases, allergies, and anti-drug antibodies. Founded in 2013, the company utilizes its proprietary Topas Particle Conjugates technology platform to induce antigen-specific immune tolerance by leveraging the liver's natural immunological processes. Topas has a clinical-stage pipeline that includes its lead product candidate, TPM203, which is currently being tested for pemphigus vulgaris, along with other programs targeting conditions such as celiac disease, Type 1 diabetes, and multiple sclerosis. The company has established research partnerships with major pharmaceutical firms, including Eli Lilly and Boehringer Ingelheim, to advance its mission of addressing significant unmet medical needs.

Onward is developing an Implantable Neuro-stimulation System (INS) with real-time motion feedback and uses training tools to rehabilitate patients suffering from neurological disorders such as spinal cord injury (SCI).

sofatutor GmbH, an edtech company, owns and operates an online learning platform for K-12 pupils and students in Europe. It offers sofatutor.com, an online platform that provides video lessons, practice problems, worksheets, and homework chat for students. The company’s website provides courses and videos in German, mathematics, primary school, English, physics, chemistry, biology, and other subjects. It serves students, teachers, and parents in Germany and internationally. sofatutor GmbH was founded in 2008 and is based in Berlin, Germany.

Kinaset Therapeutics is a therapeutics company that focuses on the advancement of novel drugs in areas of unmet medical needs. The company was founded in 2020 and is headquartered in Medfield, Massachusetts.

Topas Therapeutics GmbH is a biotechnology company based in Hamburg, Germany, that specializes in developing nanoparticle-based therapeutics aimed at treating autoimmune diseases, allergies, and anti-drug antibodies. Founded in 2013, the company utilizes its proprietary Topas Particle Conjugates technology platform to induce antigen-specific immune tolerance by leveraging the liver's natural immunological processes. Topas has a clinical-stage pipeline that includes its lead product candidate, TPM203, which is currently being tested for pemphigus vulgaris, along with other programs targeting conditions such as celiac disease, Type 1 diabetes, and multiple sclerosis. The company has established research partnerships with major pharmaceutical firms, including Eli Lilly and Boehringer Ingelheim, to advance its mission of addressing significant unmet medical needs.

Televic N.V. is a Belgium-based company that specializes in developing, manufacturing, and installing advanced communication products and solutions tailored for various sectors, including healthcare, education, railways, and conferencing. Founded in 1946, Televic offers a wide range of integrated audio-visual systems for settings such as conference rooms, auditoria, and control rooms, as well as on-board communication systems and passenger information solutions for the transportation industry. The company also provides digital networks for nurse call systems, intercoms, and patient entertainment. In education, Televic delivers innovative solutions, including digital and wireless language labs, virtualized learning environments, and classroom management software. With a commitment to high-tech quality, Televic aims to expand its global presence while maintaining a leading position in its specialized markets.

AME is an independent developer and manufacturer of high quality electronic products located in the top technological region.

JenaValve Technology GmbH specializes in the development and manufacturing of transcatheter aortic valve implantation (TAVI) systems designed for both transapical and transfemoral implantation. Founded in 2006 and headquartered in Munich, Germany, the company offers a therapeutic alternative to surgical aortic valve replacement for high-risk patients suffering from aortic heart valve stenosis. The concept for the device was initiated by cardiologists Hans-Reiner Figulla and Markus Ferrari at the Friedrich Schiller University Clinic in Jena, Germany. Early on, JenaValve recognized the importance of safety, precision, and durability in their systems, which are crucial for effective treatment and enhancing patient well-being.

General Fusion Inc. develops commercial Magnetized Target Fusion, a hybrid between magnetic fusion and inertial confinement fusion for transforming energy supply. It also develops scale subsystems, including scale plasma injectors, acoustic drivers, and liquid metal vortex compression tests. The company was founded in 2002 and is based in Burnaby, Canada.

ImCheck Therapeutics SAS is a biotechnology company incorporated in 2015 and based in Marseille, France. The company specializes in designing and developing immunotherapeutics that target the butyrophilin super-family of checkpoint molecules, specifically engaging γ9δ2 T cells. With a primary focus on immuno-oncology, ImCheck Therapeutics develops immunomodulatory antibodies aimed at treating various cancers, including breast, gastric, and ovarian cancers, as well as other immune-related diseases. The company is dedicated to addressing severe unmet medical needs through its innovative approach to cancer treatment and the development of next-generation immunotherapeutics.

iSTAR Medical SA is a Belgian company specializing in the development of innovative ophthalmic implants aimed at treating glaucoma. Founded in 2010 as a spinout of Healionics Corporation, the company has established a strong presence in the market with its flagship product, the STARflo glaucoma implant. This non-degradable, micro-porous drainage system reduces intraocular pressure in patients with open-angle glaucoma by enhancing the eye's natural uveoscleral outflow. iSTAR Medical also offers additional products, including STARflo PLUS and STARflo MINI, which provide surgical therapies for glaucoma. The implants are designed to integrate with surrounding tissue, exhibiting anti-fibrotic and anti-inflammatory properties, thereby minimizing complications and the need for medication. The company operates from its eco-friendly R&D and manufacturing facility in Belgium and distributes its products across various international markets, including Australia, China, France, Hungary, Italy, Poland, and Turkey. iSTAR Medical has received multiple quality certifications, including ISO 13485 and ISO 9001, and achieved CE Mark approval for its devices.

Biotalys is a green biotech company that employs its proprietary Agrobody technology platform to develop crop protection products. The company develops a new generation of protein-based biocontrol solutions, shaping the future of sustainable and safe food supply. Biotalys' unique protein-based biocontrols combine the high-performance characteristics of chemicals with the clean safety profile of biologicals, making them ideal crop protection agents for both pre- and post-harvest applications. It was incorporated in 2012 and is based in Ghent, Belgium.

The Alro Group is a leading provider of coating services for the automotive industry, headquartered in Dilsen-Stokkem, Belgium. With a significant presence in Western and Central Europe, the company has evolved from a small operation into a reputable group specializing in various coating techniques. Alro Group offers a range of services including wet coating, electrocoating, powder coating, and assembly, allowing clients to obtain tailored metal and plastic products that meet their specific needs.

Smart Battery Solutions GmbH develops and manufactures energy storage systems and charging technologies. The company offers unipower/unipower light products, LBP-Xell products, batteries, chargers, and cells. Its products are used for various e-mobility applications, including e-bikes, e-scooters, watercraft, and drones, as well as stationary solutions, such as constant power supply devices. The company was founded in 2010 and is based in Kleinostheim, Germany.

Camel-IDS develops radiopharmaceuticals for cancer patients. Its product, CAM-H2, treats HER2 positive cancers. It also engages in clinical development to treat breast cancer patients; and develops compounds for other cancer indications. The company was incorporated in 2014 and is based in Brussels, Belgium.

La Comtoise develops and supplies tailor-made cheese solutions to industrial food processing groups.

Medi Markt Service Nord Ost is a provider of medical aids in Germany, specializing in incontinence care, diabetes management, stoma care, enteral nutrition, tracheostomy, and various dressing materials. With over a decade of experience, the company focuses on delivering tailored solutions that meet the specific needs of patients. Their offerings also include care products and hygiene and disinfection supplies, ensuring comprehensive support for individuals managing chronic health conditions. Medi Markt Service Nord Ost aims to empower patients by providing essential resources to help them navigate their health challenges effectively.

Medi-Markt is the specialist for medical aids and care aids.

One of A Kind Technologies B.V., headquartered in Eindhoven, the Netherlands, is a holding company that specializes in camera inspection technology, vision solutions, and industrial automation products. Founded in 2012, the company has grown to include more than 65 employees across five subsidiary companies, operating globally. The company's expansion began with the acquisition of Beltech B.V., followed by VIMEC Applied Vision Technology in 2014. In subsequent years, One of A Kind Technologies established Crux Agribotics and Smart Vision Center in 2015 to explore new market opportunities and founded Uniq Engineering in 2017 to enhance turnkey engineering capabilities. The organization employs a lean model where each subsidiary manages its day-to-day operations, while the Executive Team collaborates with representatives from all disciplines to determine strategy, focusing on growth, professionalization, innovation, and synergy among the group.

Laser 2000 is an independent European suppliers of innovative laser and photonics solutions. The company's comprehensive range of products extends from lasers and light sources for the processing of materials, over measurement equipment and fibre optics to 3D imaging, optical power and energy meters as well as cameras. With more than 30 years of experience in the market, Laser 2000 is a photonics pioneer and can therefore benefit from long-standing customer and supplier relationships. It serves renowned companies and research institutes in the fields of automation and sensor technology, optical communications and network technologies, biotech and medicine, automotive and aerospace.

Impact is a temporary employment agency for specialists in technics, construction and office work. IMPACT is a specialized temporary employment agency with its headquarters in Hasselt. Their main objective? By means of a personal approach, a clear focus, and a great deal of engagement and expertise, they aim to match employers with specialists who are looking for a job in the fields of technics, construction, or office work. Thus, they contribute to the successful growth of enterprises and to the professional satisfaction of the experts who found a job thanks to them.

The group France Thermes is the organizing body of all operating subsidiaries, which include: The Thermal Resorts of Bagnoles de l'Orne (Normandy) and Châtel-Guyon (Auvergne) since January 1, 2017. The group is founded on a multi-expertise in the thermal environment, around three main skills:

Fire1, based in Dublin, Ireland, is dedicated to developing innovative therapeutic devices aimed at enhancing the lives of heart failure patients. The company has created a remote monitoring system that allows healthcare providers to access real-time patient data and insights. This technology facilitates the early detection of complications associated with heart failure, enabling proactive interventions that can lead to improved patient outcomes. Through its focus on remote monitoring, Fire1 seeks to address critical challenges in heart failure management and contribute to better healthcare solutions.

Stiplastics S.A.S. engages in designing, developing, and manufacturing medical devices for the healthcare industry

WEMAS is market leader in Germany for integrated, certified solutions for road shut-off technology. The broad range of products mainly includes shutters, fall arrestors, lights, footplates and traffic cones. The core business is supplemented by other plastic products such as mortar baths, protective devices for the logistics sector, as well as articles for horse sport. The sales are exclusively for customers as well as for the trade. At the headquarters in Gütersloh, more than 120 employees work on the satisfaction of WEMAS customers.

Cegeka is a European IT services provider based in Hasselt, Belgium, specializing in ICT solutions, services, and consulting. Established in 1986, the company has developed a comprehensive portfolio that includes end-to-end digital solutions, enterprise cloud services, cybersecurity, IT infrastructure monitoring, and ERP, APS, and CRM solutions. Cegeka also offers data intelligence and ICT outsourcing services. The company operates in ten European countries and employs over 5,000 people. It has grown significantly through both organic development and strategic acquisitions, solidifying its position as a key player in the European market. Founded originally as Tema Studio Informatica, Cegeka became a Microsoft solution provider in Italy by 1992 and has since expanded its offerings through various acquisitions, including the purchase of Brain Force and INDIS Italia. André Knaepen, the founder, led the company until 2019, when Stijn Bijnens took over as CEO.

Arseus Medical B.V. distributes medical equipment and consumables to hospital. Its products include medical devices, disposables, hygiene and disinfection products, medical instruments and small diagnostic materials, lab and testing materials, reagents, catheters, surgery equipment, instruments products, and disposables. Arseus Medical B.V. was formerly known as Omega Medical BV. The company was founded in 2002 and is based in Waalwijk, the Netherlands. Arseus Medical B.V. is a former subsidiary of Fagron NV.

MVZ Holding focusses on providing best in class primary medical care and has grown successfully by executing a disciplined expansion strategy. The company currently runs more than 25 medical practices in different regions in Switzerland and plans further expansion within the country.

ImCheck Therapeutics SAS is a biotechnology company incorporated in 2015 and based in Marseille, France. The company specializes in designing and developing immunotherapeutics that target the butyrophilin super-family of checkpoint molecules, specifically engaging γ9δ2 T cells. With a primary focus on immuno-oncology, ImCheck Therapeutics develops immunomodulatory antibodies aimed at treating various cancers, including breast, gastric, and ovarian cancers, as well as other immune-related diseases. The company is dedicated to addressing severe unmet medical needs through its innovative approach to cancer treatment and the development of next-generation immunotherapeutics.

ALT Technologies BV is a prominent manufacturer of labeling and self-adhesive products, primarily serving the automotive, durable goods, and security sectors. The company specializes in producing durable point-of-sale labels, product identification labels, warning labels, and various functional components like light diffusion labels and instrument panels. Notably, ALT Technologies is a key supplier of airbag components, including covers, wraps, and seals, ensuring that its products are integrated into nearly all major automotive brands worldwide. Founded in 2002 and headquartered in Utrecht, the Netherlands, the company operates manufacturing facilities and sales offices in Romania, China, and the United States. As of 2017, ALT Technologies functions as a subsidiary of Advanced Safety Technologies B.V., reflecting its significant role in the safety technology industry.

Biotalys is a green biotech company that employs its proprietary Agrobody technology platform to develop crop protection products. The company develops a new generation of protein-based biocontrol solutions, shaping the future of sustainable and safe food supply. Biotalys' unique protein-based biocontrols combine the high-performance characteristics of chemicals with the clean safety profile of biologicals, making them ideal crop protection agents for both pre- and post-harvest applications. It was incorporated in 2012 and is based in Ghent, Belgium.

Breath Therapeutics GmbH, based in Munich, Germany, with an additional office in Menlo Park, California, develops innovative drug-aerosol therapeutics aimed at treating bronchiolitis obliterans syndrome and other severe respiratory diseases. Founded in 2016 and now a subsidiary of Zambon S.p.A., the company focuses on combining novel formulations of existing drugs with advanced inhalation technologies. Their products include a liposomal formulation of cyclosporine A designed for inhalation, paired with a high-performance nebulizer that optimizes drug delivery. This approach allows for rapid delivery of high drug concentrations directly to the lungs, enhancing the efficacy of treatments while reducing systemic exposure. Breath Therapeutics aims to address significant unmet medical needs in rare pulmonary conditions through its targeted inhalation therapies.

Itineris NV is a technology company specializing in customer care and operational solutions for the energy and water sectors in Europe and North America. Established in 2003 and headquartered in Sint-Martens-Latem, Belgium, Itineris develops UMAX, a multi-commodity business solution designed for both regulated and deregulated markets, addressing utilities such as electricity, gas, water, and telecom. The company offers a range of services, including consultancy, implementation, project-based support, and long-term application management. Itineris also provides expertise in business process transformation, customer relationship management, and reporting solutions. As a Microsoft Gold Partner, Itineris leverages Microsoft’s ERP platform to enhance its offerings. The company maintains additional offices in Georgia and Maryland, and has formed strategic partnerships with industry leaders like Microsoft, IBM, and Capgemini.

MEGA International S.A., a software development company, develops and markets a range of software solutions to manage enterprise complexity for Fortune 500 companies, SMEs, and government agencies globally. It offers HOPEX, an integrated software solution for business process analysis, IT portfolio management, governance, risk and compliance, and platform and shared services. The company also provides HOPEX Cloud, an integrated cloud platform for software solutions to help drive business and IT transformation. In addition, it offers EAMS assessment, design, implementation, support, and training services. The company serves banking and insurance, defense and security, energy and manufacturing, government, pharma, food and chemical, retail, and telecoms and services customers. It serves its customers through a network of distributors worldwide. The company was founded in 1991 and is based in Paris, France with additional offices in the United States, Italy, Germany, the United Kingdom, México, Singapore, Morocco, and Australia.

ACCEO operates in various sectors, primarily focusing on engineering, inspection, and certification services for buildings and large structures. The company specializes in elevator engineering and offers inspection and monitoring services for vertical transportation systems. Additionally, it conducts regulated accessibility audits and energy efficiency assessments for building owners, designers, and property managers, particularly in the commercial and administrative sectors. By providing expert advice on elevator design for both new and existing buildings, ACCEO assists its clients in enhancing the performance of their properties, reducing operational costs, and increasing overall property value. The company's services extend to the hospital market, ensuring compliance with accessibility standards and promoting energy efficiency.

Spineart is a privately held medical device company focused on simplifying the surgical act by designing, developing and promoting safe and efficient solutions to spine surgeons, operating room teams, and patients. Spineart is a pioneer in its field, having introduced unique patented and clinically validated technologies in the fields of Minimally Invasive Surgery, Motion Preservation, Fusion, Biologics, and Fractures Treatment. Spineart markets a complete portfolio combining traceable barcoded sterile packed implants with compact instrument sets, thus proudly promoting greater safety, cost-efficiency, and compliance at the hospital.

Summa Technologies, Inc. is a consulting firm that specializes in providing digital solutions to businesses across the United States. The company offers a range of services, including custom software development, which encompasses strategy and experience design, software architecture, mobile and web application development, cloud platform integration, and Internet of Things (IoT) solutions. In addition to software development, Summa provides agile transformation services and Salesforce consulting. Founded in 1996 and headquartered in Pittsburgh, Pennsylvania, Summa Technologies has formed strategic partnerships with leading companies such as Salesforce, IBM, and Microsoft. The company operates as a subsidiary of CGI Group Inc. since 2017.

Riaktr is a Belgian scale-up founded in 2009 and backed by first class investors (Fortino, Endeit, GIMV). We started as a service company under the name ‘Real Impact Analytics’. At the time, Big Data was the new big thing, driving important corporate investments. Yet, too often such investments were not yielding the desired returns. Since day one, we pursue a clear mission: leverage the value of telecom data. We do this by starting from the field to build user-centric frameworks driving results. We resist the ‘black box’ principle by putting data at the service of human intelligence and bringing teams together under a collaborative approach. Our brand Riaktr, adopted in 2018, symbolizes our pivot from a services business to a product company. Today our software products address two major questions faced by telcos: - How can I optimize my network CAPEX investments? - How can I optimize my Sales & Distribution operations? Behind the scenes, we are a team of computer scientists, engineers and business consultants based in the heart of Brussels, with a local presence close to our clients in South-Africa and Brazil. We have worked in many countries in Africa, Latin America, the Caribbean and Europe. We work with six of the ten biggest telecom groups to revolutionize the telecom and Consumer Goods industries.

EndoStim, Inc., a medical device company, develops and commercializes neurostimulation solutions for the treatment of gastro-esophageal reflux disease (GERD). Its solutions cover treatment for GERD through electrical stimulation. The company distributes its products throughout Europe, Asia, and Latin America. EndoStim was founded in 2009 and is based in Dallas, Texas.

Arplas Europe BV engages in the development, application, and marketing of various welding-applications for the production of passenger cars worldwide. The company was founded in 1971 and is based in Amersfoort, the Netherlands with manufacturing, service, and training facilities in Europe, North America, and Korea; and service representatives in China and Brazil. It also has locations in Europe and Africa. Arplas Europe BV operates as a subsidiary of AL-S Technology B.V.

Joolz designs and manufactures award-winning premium pushchairs. Joolz differentiates itself through the quality of its products and ergonomic design, as well as its unique modern brand and culture. Their stylish and distinctive pushchairs are designed to positively accommodate both child and parent. Joolz goal is to inspire young families to enjoy a positive life, i.e. a sustainable and healthy lifestyle. This aim is reflected in their ergonomic products, re-usable packaging, the Joolz Birth Forest, the partners with whom they work and the steps they take in sustainability.

Onward is developing an Implantable Neuro-stimulation System (INS) with real-time motion feedback and uses training tools to rehabilitate patients suffering from neurological disorders such as spinal cord injury (SCI).

Topas Therapeutics GmbH is a biotechnology company based in Hamburg, Germany, that specializes in developing nanoparticle-based therapeutics aimed at treating autoimmune diseases, allergies, and anti-drug antibodies. Founded in 2013, the company utilizes its proprietary Topas Particle Conjugates technology platform to induce antigen-specific immune tolerance by leveraging the liver's natural immunological processes. Topas has a clinical-stage pipeline that includes its lead product candidate, TPM203, which is currently being tested for pemphigus vulgaris, along with other programs targeting conditions such as celiac disease, Type 1 diabetes, and multiple sclerosis. The company has established research partnerships with major pharmaceutical firms, including Eli Lilly and Boehringer Ingelheim, to advance its mission of addressing significant unmet medical needs.

Contraload is a fast growing Pan European company in pooling and rental services for plastic pallets and bins. For more than 10 years CLD has been focusing on plastic load carriers and has close to 1 million assets in its pool, all constantly on the move within the whole of Europe. CLD has a broad range of plastic pallets and IBCs for many different supply chains. Focus lies on the more complex food and FMCG supply chains with demanding and challenging global customers like Unilever, Nestle, Intersnack and many others. CLD helps its customers to meet the high quality and hygienic requirements, avoid foreign body contamination and to connect to suppliers or customers in a cost effective way. “CLD helps you carry the load”, so you can focus on your core business.

Itho Daalderop B.V. is a manufacturer and supplier of heating, domestic hot water, ventilation, and control technology solutions for residential and business clients in the Netherlands and abroad. Founded in 1919 and based in Schiedam, with additional locations in Etten-Leur, Tiel, the United Kingdom, and Sint-Niklaas, Belgium, the company offers a range of products including boilers, heat pumps, solar water heaters, ventilation systems, and air purification devices. Itho Daalderop also serves as an advisory partner for various stakeholders, including governments, corporations, and construction firms, across new construction, renovation, and replacement projects. As a subsidiary of Klimaatgarant B.V. since 2016, the company is committed to providing energy-efficient solutions that promote a healthy and comfortable indoor climate.

Legallais is a distributor of ironmongery, plumbing products and electricity products and is mainly active in the French market where it provides an exhaustive and high quality offering for craftsman, building operators and maintenance companies. Legallais is the reference in the market when it comes to service: in addition to a large product availability, customers can order in different ways (mobile, online, mail,...) and their automated logistics ensures a delivery within 24 hours.

Brakel has been market leader in the area of daylight access, fire safety and ventilation solutions for more than 35 years, with sales in both Europe and further afield. And we offer integral solutions for all kinds of building types comprising: Daylight Skylights, rooflights, skylights and facades Fire safety SHEV systems, fire alarm systems, detection, compartmentation Ventilation Natural ventilation, controlled natural ventilation Maintenance SHEV and ventilation systems, fire alarm systems, glass constructions

Equipe Zorgbedrijven Holding B.V. operates clinics for specialized surgery in the Netherlands. The company is headquartered in Eindhoven, the Netherlands.

Biom'Up S.A. develops and commercializes hemostatic products based on patented biopolymers. It offers HEMOBLASTTM bellows and its laparoscopic applicators to simplify the surgeons’ practices for open surgical procedures in various specialties, such as cardiac, general and orthopedic, and laparoscopic surgeries. The company markets its products in Europe and the United States. Biom'Up S.A. was founded in 2005 and is based in Saint-Priest, France.

JenaValve Technology GmbH specializes in the development and manufacturing of transcatheter aortic valve implantation (TAVI) systems designed for both transapical and transfemoral implantation. Founded in 2006 and headquartered in Munich, Germany, the company offers a therapeutic alternative to surgical aortic valve replacement for high-risk patients suffering from aortic heart valve stenosis. The concept for the device was initiated by cardiologists Hans-Reiner Figulla and Markus Ferrari at the Friedrich Schiller University Clinic in Jena, Germany. Early on, JenaValve recognized the importance of safety, precision, and durability in their systems, which are crucial for effective treatment and enhancing patient well-being.

CoScale NV provides software solutions for IT operations analytics. It offers integrated platform to monitor full stack of containerized applications. It also provides COSCALE Application Performance Analyzer software that gathers and correlates data from Web applications and the underlying infrastructure to automatically identify and isolate disruptions, inefficiencies, and failures in Web applications; and enable organizations to optimize its infrastructure. The company offers its product as a subscription and licensing model for organizations operating in areas, such as e-commerce, online banking, online customer service, etc. CoScale NV was founded in 2013 and is based in Ghent, Belgium.

Itineris NV is a technology company specializing in customer care and operational solutions for the energy and water sectors in Europe and North America. Established in 2003 and headquartered in Sint-Martens-Latem, Belgium, Itineris develops UMAX, a multi-commodity business solution designed for both regulated and deregulated markets, addressing utilities such as electricity, gas, water, and telecom. The company offers a range of services, including consultancy, implementation, project-based support, and long-term application management. Itineris also provides expertise in business process transformation, customer relationship management, and reporting solutions. As a Microsoft Gold Partner, Itineris leverages Microsoft’s ERP platform to enhance its offerings. The company maintains additional offices in Georgia and Maryland, and has formed strategic partnerships with industry leaders like Microsoft, IBM, and Capgemini.

United Dutch Breweries B.V. produces and supplies beer. The company provides lagers, non-alcoholic malt beverages, dark malt beverages, ciders, and fruit beers. It offers products through on-and off-trade distributors, and retailers worldwide. The company was founded in 1968 and is based in Breda, the Netherlands. United Dutch Breweries B.V. is a former subsidiary of Anheuser-Busch InBev SA/NV.

Teads is a prominent player in the digital advertising space, specializing in outstream video advertising and serving as a leading native video advertising marketplace. Founded in 2011 and based in New York, with additional offices in Chicago and California, the company operates a video advertising supply side platform (SSP) that enables publishers and brands to create and monetize video inventory. Teads offers various advertising solutions, including inRead formats and programmatic buying, which allow clients to leverage their own sales forces and third-party resources. The company aims to enhance user experience by providing innovative advertising formats that respect user engagement, thereby generating premium inventory. With a workforce of over 600 employees across 27 global offices, Teads has established itself as a key player in the advertising industry since becoming part of the Altice Group in 2017.

EcoChem develops and formulates eco-friendly flame retardants additives, which are mainly used in building & construction, transportation and electronic applications. The company’s products are added to materials such as wood, insulation, textiles or plastics in order to inhibit, suppress or delay flame and smoke production caused by fire. Headquartered in Olen (Belgium), EcoChem operates 2 production facilities located in Willlebroek (Belgium) and in Offenbach (Germany) and is serving clients in 25 countries.

The Well Services Group is a total well service provider for the oil and gas industry. By using well maintained 'state of the art' equipment and experienced personnel we can offer high quality services with a high efficiency. By being a flexible operating company we can respond fast to the costumers needs.

Mackevision Medien Design GmbH is one of the global market leaders in Computer Generated Imagery (CGI). It provides data-based 3D visualization, animation and visual effects. The company designs and produces image and film material, as well as interactive applications in high-end quality.It develops technological solutions for generating images and accompanies the entire CGI process from data preparation to creative design to the finished product.

Launched in 2007 by entrepreneur and mother of five Nathalie Christen-Genty, MELIJOE.COM is the world’s premier online fashion e-tailer for children ages 0-16. Featuring the latest in childrenswear trends inspired directly by adult runways, MELIJOE.COM is home to some of the industry’s most sought-after labels in kid’s fashion. MELIJOE.COM is above all an international brand, featuring 100% authentic products, speedy worldwide shipping and a website translated in six languages. Thanks to a developed editorial strategy and magazine-inspired web layout, MELIJOE.COM doubles as a digital news outlet for children’s fashion with Le Magazine, and between exclusive shopping edits, childrenswear news, trend reports and in-house photo shoots, MELIJOE.COM is an extra-large world of digital fashion for the smallest of fashionistas.

Thinkstep enables organizations worldwide to succeed sustainably. Their industry-leading software, data and services drive operational excellence, product innovation, brand value and regulatory compliance. With a global presence in 19 countries they serve more than 2,000 companies, including 40 percent of the Fortune 500 such as BASF, Hewlett-Packard, Interface, Siemens, Unilever and Volkswagen.

Ablynx NV is a clinical biopharmaceutical company based in Ghent, Belgium, that specializes in the discovery and development of Nanobodies, a novel class of therapeutic proteins derived from single-domain antibody fragments. The company focuses on addressing serious human diseases, including inflammation, hematology, oncology, and respiratory conditions. Ablynx has a diverse pipeline with approximately 25 projects, featuring five Nanobodies currently in clinical development. Notable clinical programs include caplacizumab for acquired thrombotic thrombocytopenic purpura, ALX-0171 for respiratory syncytial virus infection, and Vobarilizumab for rheumatoid arthritis and systemic lupus erythematosus. Other ongoing trials involve treatments for psoriasis, solid tumors, chronic kidney diseases, and bone-loss related disorders. Ablynx has established collaboration agreements with several major pharmaceutical companies to advance its research and development efforts. Founded in 2001, Ablynx was formerly known as MatchX and rebranded in 2002. The company operates as a subsidiary of Sanofi.

JenaValve Technology GmbH specializes in the development and manufacturing of transcatheter aortic valve implantation (TAVI) systems designed for both transapical and transfemoral implantation. Founded in 2006 and headquartered in Munich, Germany, the company offers a therapeutic alternative to surgical aortic valve replacement for high-risk patients suffering from aortic heart valve stenosis. The concept for the device was initiated by cardiologists Hans-Reiner Figulla and Markus Ferrari at the Friedrich Schiller University Clinic in Jena, Germany. Early on, JenaValve recognized the importance of safety, precision, and durability in their systems, which are crucial for effective treatment and enhancing patient well-being.

With its complementary geographic footprint, expertise and service offerings, Transdev offers a unique response to public transport needs. Transdev keeps operations and decision-making local and close to the client, backed up with consistent, high-quality standards that leverage the company's international expertise, best practices and resources in order to deliver industry-leading results. Transdev, an incorporated company with its own Board of Directors, is supported by its two major shareholders, Caisse des Depôts and Veolia Environnement. Listening to customers, anticipating and responding to their needs and expectations, constantly seeking ways to provide simpler, more accessible and more personalized service. Transdev strives to make each trip a unique experience, with passion and commitment.

Covagen develops bispecific FynomAbs by fusing its human Fynomer binding proteins to antibodies, resulting in therapeutics with novel modes of action and enhanced efficacy in the treatment of inflammatory diseases and cancer. The ability to fuse Fynomers to multiple sites on an antibody allows Covagen to create FynomAbs with tailored architectures to maximize efficacy. Their goal is to access novel biology for each product candidate. Covagen’s lead FynomAb COVA322 is being developed for the treatment of inflammatory diseases such as rheumatoid arthritis and psoriatic arthritis. In October 2012 Covagen entered into a strategic research collaboration and license agreement with Mitsubishi Tanabe / TRL for the development of bispecific FynomAbs against target pairs selected by Mitsubishi Tanabe / TRL. Covagen was founded in 2007 as a spin-off company from ETH Zurich (Swiss Federal Institute of Technology). A strong syndicate of investors supports Covagen’s drug development programs including Novartis Venture Fund, Edmond de Rothschild Investment Partners, Gimv, Seroba Kernel Life Sciences, Ventech, Ascent Biomedical Venture Management, MP Healthcare Venture Management, and Baxter Ventures.

Eurocept, an Ankeveen, the Netherlands-based healthcare company. Founded in 2001 by CEO Mike van Woensel, Eurocept sells specialized medicines and provides medical homecare services. Eurocept Pharmaceuticals is responsible for the registration, marketing, distribution and sale of speciality medicines in the fields of anesthetics, psychiatry, urology, pediatrics and infectious diseases. Eurocept Homecare provides medical specialist homecare and related out-patient medical technology for medicine and food administration.

Almaviva Santé owns and operates hospitals and health care clinics. The company was founded in 2007 and is headquartered in Marseille, France.

Endosense is a medical technology company specializing in catheter ablation for the treatment of cardiac arrhythmias. The company has developed the TactiCath, the first and only force-sensing ablation catheter that provides physicians with a real-time, objective measure of contact force during procedures. Since receiving the CE mark in May 2009, the TactiCath has undergone extensive pre-clinical and clinical testing, establishing a strong foundation of evidence for the safety and efficacy of contact force sensing in catheter ablation. Through its innovative approach, Endosense aims to enhance the effectiveness and reproducibility of arrhythmia treatments.

NovoPolymers NV develops encapsulant solutions for the photovoltaic market. It offers thermoplastic encapsulant sheets for crystalline silicon based photovoltaic modules; and hydrocarbon thermoplastic elastomer materials. The company was founded in 2008 and is based in Puurs, Belgium.

JenaValve Technology GmbH specializes in the development and manufacturing of transcatheter aortic valve implantation (TAVI) systems designed for both transapical and transfemoral implantation. Founded in 2006 and headquartered in Munich, Germany, the company offers a therapeutic alternative to surgical aortic valve replacement for high-risk patients suffering from aortic heart valve stenosis. The concept for the device was initiated by cardiologists Hans-Reiner Figulla and Markus Ferrari at the Friedrich Schiller University Clinic in Jena, Germany. Early on, JenaValve recognized the importance of safety, precision, and durability in their systems, which are crucial for effective treatment and enhancing patient well-being.

Complix NV is a biopharmaceutical company based in Diepenbeek, Belgium, with research facilities in Zwijnaarde, Belgium, and an office in Esch-sur-Alzette, Luxembourg. Founded in 2008, the company specializes in the discovery and development of Alphabodies, a novel class of protein therapeutics designed to target difficult disease sites, particularly in oncology and autoimmune diseases. These Alphabodies demonstrate high affinity for a variety of disease targets and possess unique stability and versatility, enabling non-injectable delivery methods. Complix aims to address challenging intracellular targets, thereby offering patients alternatives to traditional antibodies and small molecules, with the intent of improving treatment outcomes for complex conditions such as cancer, autoimmune disorders, and viral diseases.

Luciad provides high performance software tools for rapid application development of advanced systems. Our applications simplify the lives of developers and end users with advanced visual analytics that allow them to unlock the potential of real time location intelligence and create the foundations for next generation geospatial systems. From safeguarding critical assets to creating the digital infrastructure for smart cities, we help users implement intuitive command and control systems. Our customers depend on Luciad for high performance visualization that allows them to implement scalable solutions.

Marco Vasco SAS is a travel agency specializing in tailor-made journeys, focusing on adventure and honeymoon travel across various global destinations, including Asia, Africa, the Americas, and Europe. Founded in 2005 and based in Paris, France, the company has established itself as a leader in the online custom holiday market. It operates with a subsidiary office in Shanghai, China. Since its inception, Marco Vasco has shown significant growth, becoming profitable in 2010 and expanding its revenues from 1 million euros in 2008 to 60 million euros in 2013 through organic growth. The company was formerly known as Planetveo and Prestige Voyages SAS, and as of November 30, 2017, it operates as a subsidiary of Société du Figaro, SAS.

Lampiris, an independent supplier of gas, green power and energy services such as insulation, furnace maintenance, wood and pellets for heating, and smart thermostats, has been active in the Belgian energy market since 2005. Lampiris, which currently supplies more than a million accounts, is the third-largest supplier in the residential energy market in Belgium.

Multiplicom N.V. is a Belgian company specializing in the development of molecular diagnostic test kits aimed at gathering genetic information for personalized treatment. Founded in 2010 and headquartered in Niel, Belgium, with an additional office in Lyon, France, the company provides a range of diagnostic assays across human, oncology, and prenatal applications. Its human application segment includes products for cancer, genetic, and cardiac disorders, such as various BRCA assays and tests for conditions like Marfan syndrome and cystic fibrosis. In the oncology segment, Multiplicom offers assays for molecular tumor pathology and cancer genetics. The prenatal application features the Clarigo product, which screens for chromosome abnormalities. The company operates a MASTR facility in Niel and an informatics facility in Gent, Belgium. Since January 2017, Multiplicom has functioned as a subsidiary of Agilent Technologies, Inc.

McPhy Energy S.A. develops and supplies hydrogen production, storage, and distribution equipment for hydrogen energy, zero emission mobility, and industrial hydrogen markets worldwide. The company offers alkaline electrolyzers, including small, medium, and large hydrogen production units; and hydrogen storage solutions. It also designs medium and large hydrogen stations; and integrated hydrogen solutions. The company was founded in 2008 and is based in La Motte, France.

Biotalys is a green biotech company that employs its proprietary Agrobody technology platform to develop crop protection products. The company develops a new generation of protein-based biocontrol solutions, shaping the future of sustainable and safe food supply. Biotalys' unique protein-based biocontrols combine the high-performance characteristics of chemicals with the clean safety profile of biologicals, making them ideal crop protection agents for both pre- and post-harvest applications. It was incorporated in 2012 and is based in Ghent, Belgium.

Established in 1997, Proxiad is a consulting and expertise company in new technologies and information systems. Expert in digital innovation, we develop a unique know-how by accompanying our 710 employees in their professional development so that they are constantly advancing and always at the forefront of technology, in a humanely pleasant and motivating context.

Jeeng is a product developed by PowerInbox, Inc., a company that specializes in multichannel digital monetization solutions for publishers and marketers. Jeeng focuses on enhancing user engagement through automated push notifications and email alerts, leveraging real-time capabilities to revitalize static mail programs. The platform integrates seamlessly with existing email programs, allowing marketers, agencies, and email service providers to implement personalized and targeted campaigns effectively. By combining dynamic animation and geographic targeting, Jeeng aims to improve click-through rates and overall user interaction. Founded in 2010 and based in New York, PowerInbox continues to provide innovative solutions backed by leading venture capital firms.

Endosense is a medical technology company specializing in catheter ablation for the treatment of cardiac arrhythmias. The company has developed the TactiCath, the first and only force-sensing ablation catheter that provides physicians with a real-time, objective measure of contact force during procedures. Since receiving the CE mark in May 2009, the TactiCath has undergone extensive pre-clinical and clinical testing, establishing a strong foundation of evidence for the safety and efficacy of contact force sensing in catheter ablation. Through its innovative approach, Endosense aims to enhance the effectiveness and reproducibility of arrhythmia treatments.

Ambit Biosciences is a privately-held biopharmaceutical company engaged in the discovery and development of small molecule kinase inhibitors for the treatment of cancer, inflammatory disease, and other indications. Ambit's lead compound, AC220, is a novel, potent, highly selective, orally bioavailable FMS-like tyrosine kinase-3 (FLT3) inhibitor, and is currently under clinical investigation in patients with relapsed or refractory AML. Ambit is developing AC220 in collaboration with Astellas Pharma Inc. as part of a worldwide agreement to jointly develop and commercialize FLT3 kinase inhibitors in oncology and non-oncology indications. In addition to AC220, Ambit's clinical pipeline includes AC480, a pan-HER inhibitor, and AC430, an oral JAK2 inhibitor. Ambit also has a pipeline of preclinical candidates which includes CEP-32496, a BRAF inhibitor licensed to Cephalon.

GOVECS, founded in 2009, focuses on the development, production, and marketing of electric vehicles. The company aims to deliver clean, efficient, and reliable transportation solutions through advanced technology in electric mobility. A team of skilled engineers and designers is engaged in creating electric vehicles that blend style with functionality, promoting a sustainable approach to personal and urban transport. GOVECS is committed to advancing the electric mobility sector, making it accessible and affordable for a wider audience.

Movea is a provider of motion sensing and data fusion software, firmware, and IP for the consumer electronics, particularly smart phones and tablets, sports and fitness and eHealth industries. Movea's proprietary SmartMotion™ technology - unique motion processing capabilities - enable customers and partners to quickly add motion intelligence to their products, providing reduced risk, cost, and time-to-market advantages for delivering compelling new motion-based features that create more value and a more exciting user experience for the consumer. Movea has a global presence with headquarters in Grenoble, France, a U.S. subsidiary in Silicon Valley, California, as well as technology and manufacturing partners and distributors around the world. The company was recently named a “Cool Vendor for 2012” by leading analyst firm Gartner Inc. Movea, Inc. was formerly known as Gyration, Inc. and changed its name to Movea, Inc. in January 2008. The company was founded in 1989 and is based in Milpitas, California. As of December 21, 2007, Movea, Inc. operates as a subsidiary of Movea SA.

ARS Traffic & Transport Technology has been providing traffic and transport technology solutions to businesses and government bodies since 1997. It is active in its home market of the Netherlands, but also internationally. The intelligent transport system market is always on the move, in every sense of the word. A dynamic market like this demands a specialised partner, able to cost-effectively integrate state-of-the-art, client-specific technology with existing systems, but also able to develop new hi-tech concepts.

Prosonix Ltd. operates as a specialty pharmaceutical company, which develops and markets a portfolio of inhaled respiratory medicines to treat asthma and chronic obstructive pulmonary diseases. It develops generic mono and combination therapies based on inhaled corticosteroids (ICS), long-acting beta agonists (LABA), and long-acting muscarinic antagonists (LAMA); and dual and triple combination therapies for respiratory diseases based on its multiple-component particle technology. The company was founded in 2006 and is based in Oxford, United Kingdom. As of June 15, 2015, Prosonix Ltd. operates as a subsidiary of Circassia Limited.

NovoPolymers NV develops encapsulant solutions for the photovoltaic market. It offers thermoplastic encapsulant sheets for crystalline silicon based photovoltaic modules; and hydrocarbon thermoplastic elastomer materials. The company was founded in 2008 and is based in Puurs, Belgium.

GreenWatt is an established CleanTech company offering full engineering services, covering feasibility study conception, construction and starting up of turn key small scale biogas plants around innovative and unique patented technologies solving all key issues of anaerobic digestion.

Oldelft B.V., based in Delft, Netherlands, specializes in the manufacture of transesophageal echocardiography (TEE) ultrasound transducers for the adult, pediatric, and neonatal cardiology markets. The company offers a range of products, including matrix TEE probes, motorized adult multiplane TEE probes, and pediatric TEE transducers. Recognized for its expertise in miniaturizing transducers, Oldelft serves as a key component supplier to global original equipment manufacturers (OEMs) of ultrasound systems, which are utilized in hospitals and medical institutions. The company is particularly noted for its high-quality probes designed for diagnosing cardiovascular disorders in diverse patient populations, including children and preterm infants. Oldelft actively engages in research and development, collaborating with technical and medical universities to explore innovative product designs and advance its offerings in the ultrasound market.

Prosensa is a biopharmaceutical company that specializes in the discovery, development, and commercialization of RNA-based therapeutics. It is particularly focused on addressing genetic disorders, with a primary emphasis on neuromuscular conditions. The company recognizes significant market opportunities in the healthcare sector for innovative products targeting genetic disorders, anti-infectives, and oncology. To maximize commercial potential, Prosensa plans to leverage its strong intellectual property position while primarily outsourcing its operations to specialized organizations. Through this strategy, the company aims to develop novel therapeutics that can address unmet medical needs in various therapeutic areas.

Pronota NV is developing and commercialising first-in-class diagnostics for early detection of life-threatening conditions and unmet medical needs including heart failure, pre-eclampsia and sepsis. Pronota's non-invasive, validated, diagnostics are proprietary and focused on improving quality of care for patients. Backed by a solid base of investors including GIMV, LSP, KBC Private Equity and JJDC, and a wide network of renowned key opinion leaders, Pronota is committed to making a difference in diagnosis and personalized healthcare. Pronota NV was formerly known as Peakadilly NV and changed its name to Pronota NV in November 2006. The company was founded in 2004 and is based in Zwijnaarde, Belgium.

VCST is a world-class automotive supplier of precision-machined powertrain and brake components for Automotive OEM’s and Tier 1 suppliers. The company realized a turnover of 169 million euro in 2015 and employs 1250 full time employees. VCST has production facilities in Belgium, China, Germany, Mexico and Romania, with its headquarters located in Belgium.

Trustteam NV is a provider of comprehensive information technology solutions for businesses, established in 2002 and headquartered in Kortrijk, Belgium, with additional locations in Heusden-Zolder and Paris. The company specializes in a range of services including cloud solutions, security, telephony, software, hardware, and IT consulting. Trustteam focuses on delivering outsourced IT management services that address various technology-related challenges faced by enterprises. By offering a complete suite of services, including security awareness training and digitization, Trustteam helps clients from diverse industries streamline their operations and concentrate on their core business activities, effectively alleviating their IT concerns.

ActivePath, Inc. develops interactive email and messaging solutions for banks and healthcare providers. It offers ActiveMail, an email banking system. The company also provides card services that deliver paperless e-statements and alerts directly to consumers’ personal email for viewing, ePayment, and live interaction. In addition, it offers E-Business solutions, which create a personal and convenient email channel that enables instant two-way communications and drives online transactions; and support services. The company’s solutions allows banks, card services companies, and brokerage houses to overcome the limitations of email systems, enabling them to capitalize on email as a communications, sales, and marketing channel. It also offers its email solutions for insurance, healthcare, and government organizations. ActivePath was formerly known as PostalGuard Ltd. The company was founded in 2007 and is based in Tel Aviv, Israel with additional office in Deerfield Beach, Florida. As of March 27, 2018, ActivePath Solutions Ltd. operates as a subsidiary of Broadridge Financial Solutions, Inc.

Seedcamp is a London-based venture capital investment firm founded in 2007, specializing in early-stage investments in technology sectors, including fintech and healthcare, across various global markets. The firm focuses on identifying and supporting exceptional founders who are addressing significant challenges through innovative solutions. Over the past decade, Seedcamp has invested in more than 260 startups, including well-known companies like TransferWise, Revolut, and UiPath. By providing immediate access to capital, extensive support, and a robust network, Seedcamp aims to accelerate the growth of its portfolio companies. The collective achievements of Seedcamp's startups have led to over $1 billion in additional funding from prominent investors, reflecting the firm's commitment to fostering a thriving entrepreneurial ecosystem in Europe and beyond.